Publication Name	World Journal of Gastroenterology
Manuscript ID	13935
Country	United States

Received	2014-09-09 08:02
Peer-Review Started	2014-09-09 14:06
To Make the First Decision	2014-10-14 16:59
Return for Revision	2014-10-15 17:23
Revised	2014-10-29 06:25
Second Decision	2014-11-11 09:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-11-19 09:12
Articles in Press	2014-11-19 09:40
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-12-25 11:40
Publish the Manuscript Online	2015-01-07 11:07

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Basic Study
Article Title	Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis
Manuscript Source	Unsolicited Manuscript
All Author List	Arseima Y Del Valle-Pinero, LeeAnne B Sherwin, Ethan M Anderson, Robert M Caudle and Wendy A Henderson
Funding Agency and Grant Number	Funding Agency Grant Number National Institutes of Health grant NS045614 Ruth L. Kirschstein National Research Service Award 1F31 DK083165-01A1 Division of Intramural Research, National Institute of Nursing Research 1ZIANR000018-01-05(to Henderson WA) Intramural Training Award to Del Valle-Pinero AY and Sherwin LB
Corresponding Author	Dr. Wendy A Henderson, PhD, Chief, Digestive Disorders Unit, Biobehavioral Branch, Division of Intramural Research, National Institute of Nursing Research, National Institutes of Health, Department of Health and Human Services, Bethesda, MD 20892, United States. hendersw@mail.nih.gov
Key Words	Irritable bowel syndrome; Vasoactive intestinal peptide; Trinitrobenzene sulfonic acid; Gene expression; PCR arrays
Core Tip	The present study reports evidence of altered vasoactive intestinal peptide (VIP) in both humans with irritable bowel syndrome (IBS) and a rat model with induced colitis by trinitrobenzene sulfonic acid. Together these observations provide additional evidence of the role of VIP, and the potential therapeutic application in patients with IBS. The results provide a basis for future studies to elucidate the understanding of the expression, physiology, and pharmacological properties of VIP.
Publish Date	2015-01-07 11:07
Citation	Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1): 155-163
URL	http://www.wjgnet.com/1007-9327/full/v21/i1/155.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i1.155

Full Article (PDF)	WJG-21-155.pdf
Full Article (Word)	WJG-21-155.doc
Manuscript File	13935-Review.docx
Answering Reviewers	13935-Answering reviewers.pdf
Copyright License Agreement	13935-Copyright assignment.pdf
Peer-review Report	13935-Peer review(s).pdf
Scientific Misconduct Check	13935-CorssCheck.jpg
Scientific Editor Work List	13935-Scientific editor work list.pdf